Virologicfail- ureoccurredin3participants (9 %) and was associated with low or undetect- able plasma atazanavir concentrations in 2 participants.
Viro- logicfailurewasnotassociatedwiththe development of PI resistance muta- tions, and viremia resuppressed to be- low 50 copies/mL in all participants who experienced failure.